drugset / Trial / NCT05507398
The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer
RandomizedParallel-groupSingle-blindTreatment
Summary
This study aims at evaluating and comparing the anti-tumor effects of metformin and statins (hydroxyl-methyl-glutaryl-CoA reductase inhibitors) in patients with non-metastatic breast cancer (stage I, II, \& III).
Timeline
- Start
- 2022-10
- Primary completion
- 2023-07
- Completion
- 2023-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin | Small molecule | 20 mg | — |
| Comparator | Metformin | Small molecule | 1000 mg | — |